# STRONG - Study of AGN1 LOEP for the Treatment of the Contralateral Femur After Fragility Fracture

> **NCT03268356** · NA · COMPLETED · sponsor: **AgNovos Healthcare, LLC** · enrollment: 13 (actual)

## Conditions studied

- Hip Fractures
- Osteoporosis, Postmenopausal

## Interventions

- **DEVICE:** AGN1 Femoral Local Osteo-Enhancement Procedure Kit

## Key facts

- **NCT ID:** NCT03268356
- **Lead sponsor:** AgNovos Healthcare, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-15
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2022-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03268356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03268356, "STRONG - Study of AGN1 LOEP for the Treatment of the Contralateral Femur After Fragility Fracture". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03268356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*